News
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...
The potential move to rescind authorization of Pfizer's vaccine could leave some kids in the U.S. with no available shots ...
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
The release of COVID-19 vaccine results days after the 2020 election may have not been a "coincidence" -- and could have been part of an effort by senior Pfizer executives to "deliberately slow ...
Dr Aseem Malhotra, a British cardiologist, a close associate of Robert F Kennedy Jr, claims that the Trump administration is ...
5h
KFF Health News on MSNKennedy’s anti-vaccine strategy risks forcing shots off market, manufacturers warn
By Stephanie Armour, KFF Health News Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer ...
Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the delta variant after receiving a third dose of vaccine are greater than 11-fold than following a second dose.
Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...
The FDA authorized Pfizer's COVID-19 vaccine for people 16 and up, but warned that those with allergic reactions to any of the vaccine's components should avoid it.
Pfizer's early data has spotlighted the future of COVID-19 vaccine distribution, particularly because the company's vaccine presents a potential hurdle: It needs to be stored at around -70 degrees ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results